These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28987513)

  • 1. Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles.
    Kimura S; Kiriyama A; Araki K; Yoshizumi M; Enomura M; Inoue D; Furubayashi T; Yutani R; Teraoka R; Tanaka A; Kusamori K; Katsumi H; Yamamoto A; Iga K; Sakane T
    Eur J Pharm Biopharm; 2018 Jan; 122():1-5. PubMed ID: 28987513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the Direct Contact of Amorphous Solid Particles with the Surface of Monolayers for the Transepithelial Permeation of Curcumin.
    Kimura S; Kasatani S; Tanaka M; Araki K; Enomura M; Moriyama K; Inoue D; Furubayashi T; Tanaka A; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Mol Pharm; 2016 Feb; 13(2):493-9. PubMed ID: 26656401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism.
    Kimura S; Kiriyama A; Nishimura E; Sakata S; Inoue D; Furubayashi T; Yutani R; Tanaka A; Kusamori K; Katsumi H; Iga K; Yamamoto A; Sakane T
    Biol Pharm Bull; 2018; 41(12):1769-1777. PubMed ID: 30504679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trade-off between solubility enhancement and physical stability upon simultaneous amorphization and nanonization of curcumin in comparison to amorphization alone.
    Wong JJL; Yu H; Lim LM; Hadinoto K
    Eur J Pharm Sci; 2018 Mar; 114():356-363. PubMed ID: 29309874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS; Cho CW
    Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray-dried curcumin nanoemulsion: A new road to improvement of oral bioavailability of curcumin.
    Hu L; Hu Q; Yang C
    Pak J Pharm Sci; 2018 Jan; 31(1):169-173. PubMed ID: 29348099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine.
    Wang R; Han J; Jiang A; Huang R; Fu T; Wang L; Zheng Q; Li W; Li J
    Int J Pharm; 2019 Apr; 561():9-18. PubMed ID: 30817985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Permeability and Bioavailability Enhancement of Curcumin by Nanoemulsion via Pulmonary Administration.
    Shi L; Qu Y; Li Z; Fan B; Xu H; Tang J
    Curr Drug Deliv; 2019; 16(8):751-758. PubMed ID: 31722658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Curcumin Bioavailability by Encapsulation in Sophorolipid-Coated Nanoparticles: An in Vitro and in Vivo Study.
    Peng S; Li Z; Zou L; Liu W; Liu C; McClements DJ
    J Agric Food Chem; 2018 Feb; 66(6):1488-1497. PubMed ID: 29378117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System.
    Hu L; Shi Y; Li JH; Gao N; Ji J; Niu F; Chen Q; Yang X; Wang S
    AAPS PharmSciTech; 2015 Dec; 16(6):1327-34. PubMed ID: 25804949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
    Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
    Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells.
    Kumar A; Ahuja A; Ali J; Baboota S
    Drug Deliv; 2016; 23(1):214-29. PubMed ID: 24825490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.